RxDoctor Payments DataLook up a doctor →

Anna Short

Nurse Practitioner · Roeland Park, KSNPI 1033428735

Payments from drug & device makers

$214,693in general payments, 2019–2025

Across 651 payments — averaging $329.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$188K
  • Axsome Therapeutics, Inc.$17K
  • Pfizer$6K
  • Biohaven Pharmaceutical Holding Company Ltd.$619
  • Medtronic$571
  • Amgen$526
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$35,32316%
  • Speaking & faculty fees$141,53866%
  • Travel & lodging$25,98712%
  • Food & beverage$11,8466%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$214,693 in reported general payments places this provider in the 95th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$61,567
Medicare patients
125
Services billed
5,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$31,964
EliquisApixaban15$9,118
Aimovig AutoinjectorErenumab-Aooe12$9,066
Tresiba Flextouch U-100Insulin Degludec15$3,299
Bupropion XlBupropion Hcl31$743
Atorvastatin Calcium86$738
Gabapentin74$727
Paroxetine Hcl13$447
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$441
Celecoxib14$425
Pantoprazole Sodium44$379
Lisinopril59$369
Fluticasone Propionate12$350
Tizanidine Hcl42$318
Albuterol Sulfate HfaAlbuterol Sulfate14$292

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$6,136$9,11815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Roeland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →